Ras activation modulates methylglyoxal-induced mesangial cell apoptosis through superoxide production

Wei Jan Huang1, Chun Wu Tung, Cheng Ho

  • 1Chiayi Campus, Chang Gung Institute of Technology, Pu-tzu City, Chiayi, Taiwan.

Renal Failure
|November 13, 2007
PubMed
Abstract

Insights

Methylglyoxal induces apoptosis in kidney cells by activating Ras and superoxide-mediated P38/c-Jun pathways. Inhibiting these pathways protects against methylglyoxal-induced cell death, offering potential therapeutic targets for diabetic nephropathy.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic nephropathy is linked to methylglyoxal (MGO), a dicarbonyl compound.
  • MGO induces apoptosis in renal mesangial cells, but upstream redox signaling is unclear.

Purpose of the Study:

  • Elucidate the molecular mechanism of methylglyoxal-induced apoptosis in renal cells.
  • Investigate the role of redox signaling, specifically Ras, superoxide, P38, and c-Jun pathways.

Main Methods:

  • Rat mesangial cells were treated with methylglyoxal and inhibitors (superoxide dismutase, diphenyloniodium, SB203580, manumycin A).
  • Assessed cell viability, apoptosis (Annexin-V, TUNEL), and activation of signaling proteins (Ras, P38, c-Jun, caspase-3).

Main Results:

  • Methylglyoxal reduced cell viability and induced apoptosis.
  • Superoxide mediated MGO-induced caspase-3 cleavage.
  • Inhibitors of superoxide, Ras, and P38 attenuated MGO-induced apoptosis and signaling pathway activation.
  • MGO enhanced Ras activation, leading to superoxide-mediated P38 and c-Jun activation.

Conclusions:

  • Methylglyoxal triggers apoptosis in renal mesangial cells via Ras-modulated, superoxide-dependent activation of P38 and c-Jun.
  • Targeting these pathways may offer a strategy to mitigate MGO-induced kidney damage in diabetic nephropathy.